CD28 and Miyoshi myopathy: The induction of anti-MM-Id peptide responses has been studied following the vaccination of MM patients with autologous Id-pulsed dendritic cells [30] and a recent trial (#NCT01426828) aims to evaluate whether infusion of Id-KLH primed CD3/CD28 activated autologous lymphocytes mediates a clinically relevant Id-specific immunity..